Abstract
Polyglutamine expansions in the ataxin-2 gene (ATXN2) cause autosomal dominant spinocerebellar ataxia type 2 (SCA2), but have recently also been associated with amyotrophic lateral sclerosis (ALS). We present clinical and pathological features of a family in which a pathological ATXN2 expansion led to frontotemporal lobar degeneration with ALS (FTLD-ALS) in the index case, but typical SCA2 in a son, and compare the neuropathology with a case of typical SCA2. The index case shares the molecular signature of SCA2 with prominent polyglutamine and p62-positive intranuclear neuronal inclusions mainly in the pontine nuclei, while harbouring more pronounced neocortical and spinal TDP-43 pathology. We conclude that ATXN2 mutations can cause not only ALS, but also a neuropathological overlap syndrome of SCA2 and FTLD presenting clinically as pure FTLD-ALS without ataxia. The cause of the phenotypic heterogeneity remains unexplained, but the presence of a CAA-interrupted CAG repeat in the FTLD case in this family suggests that one potential mechanism may be variation in repeat tract composition between members of the same family.
References
Abe K, Ikeda Y, Kurata T, Ohta Y, Manabe Y, Okamoto M, Takamatsu K, Ohta T, Takao Y, Shiro Y, Shoji M, Kamiya T, Kobayashi H, Koizumi A (2012) Cognitive and affective impairments of a novel SCA/MND crossroad mutation Asidan. Eur J Neurol 19(8):1070–1078. doi:10.1111/j.1468-1331.2012.03669.x
Almeida-Silva UC, Hallak JE, Junior WM, Osorio Fde L (2013) Association between spinocerebellar ataxias caused by glutamine expansion and psychiatric and neuropsychological signals—a literature review. Am J Neurodegener Dis 2(2):57–69
Burk K, Globas C, Bosch S, Graber S, Abele M, Brice A, Dichgans J, Daum I, Klockgether T (1999) Cognitive deficits in spinocerebellar ataxia 2. Brain 122(Pt 4):769–777
Burk K, Globas C, Bosch S, Klockgether T, Zuhlke C, Daum I, Dichgans J (2003) Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol 250(2):207–211. doi:10.1007/s00415-003-0976-5
Cancel G, Stevanin G, Durr A, Chneiweiss H, Penet C, Pothin Y, Agid Y, Brice A (1995) SCA2 is not a major locus for ADCA type I in French families. Am J Med Genet 60(5):382–385. doi:10.1002/ajmg.1320600507
Chong SS, McCall AE, Cota J, Subramony SH, Orr HT, Hughes MR, Zoghbi HY (1995) Gametic and somatic tissue-specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1. Nat Genet 10(3):344–350. doi:10.1038/ng0795-344
Corrado L, Mazzini L, Oggioni GD, Luciano B, Godi M, Brusco A, D’Alfonso S (2011) ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum Genet 130(4):575–580. doi:10.1007/s00439-011-1000-2
Daoud H, Belzil V, Martins S, Sabbagh M, Provencher P, Lacomblez L, Meininger V, Camu W, Dupre N, Dion PA, Rouleau GA (2011) Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis. Arch Neurol 68(6):739. doi:10.1001/archneurol.2011.111
Durr A, Smadja D, Cancel G, Lezin A, Stevanin G, Mikol J, Bellance R, Buisson GG, Chneiweiss H, Dellanave J et al (1995) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 118(Pt 6):1573–1581
Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rub U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466(7310):1069–1075. doi:10.1038/nature09320
Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G (1999) Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol 97(3):306–310
Flot J-F, Tillier A, Samadi S, Tillier S (2006) Phase determination from direct sequencing of length-variable DNA regions. Mol Ecol Notes 6(3):627–630. doi:10.1111/j.1471-8286.2006.01355.x
Furtado S, Payami H, Lockhart PJ, Hanson M, Nutt JG, Singleton AA, Singleton A, Bower J, Utti RJ, Bird TD, de la Fuente-Fernandez R, Tsuboi Y, Klimek ML, Suchowersky O, Hardy J, Calne DB, Wszolek ZK, Farrer M, Gwinn-Hardy K, Stoessl AJ (2004) Profile of families with Parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 19(6):622–629. doi:10.1002/mds.20074
Gambardella A, Annesi G, Bono F, Spadafora P, Valentino P, Pasqua AA, Mazzei R, Montesanti R, Conforti FL, Oliveri RL, Zappia M, Aguglia U, Quattrone A (1998) CAG repeat length and clinical features in three Italian families with spinocerebellar ataxia type 2 (SCA2): early impairment of Wisconsin card sorting test and saccade velocity. J Neurol 245(10):647–652
Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM (1997) The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet 60(4):842–850
Gierga K, Burk K, Bauer M, Orozco Diaz G, Auburger G, Schultz C, Vuksic M, Schols L, de Vos RA, Braak H, Deller T, Rub U (2005) Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol 109(6):617–631. doi:10.1007/s00401-005-1014-8
Gispert S, Kurz A, Waibel S, Bauer P, Liepelt I, Geisen C, Gitler AD, Becker T, Weber M, Berg D, Andersen PM, Kruger R, Riess O, Ludolph AC, Auburger G (2012) The modulation of amyotrophic lateral sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis 45(1):356–361. doi:10.1016/j.nbd.2011.08.021
Giunti P, Sabbadini G, Sweeney MG, Davis MB, Veneziano L, Mantuano E, Federico A, Plasmati R, Frontali M, Wood NW (1998) The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain 121(Pt 3):459–467
Hart MP, Brettschneider J, Lee VM, Trojanowski JQ, Gitler AD (2012) Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions. Acta Neuropathol 124(2):221–230. doi:10.1007/s00401-012-0985-5
Hayes S, Turecki G, Brisebois K, Lopes-Cendes I, Gaspar C, Riess O, Ranum LP, Pulst SM, Rouleau GA (2000) CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). Hum Mol Genet 9(12):1753–1758
Ikeda Y, Ohta Y, Kobayashi H, Okamoto M, Takamatsu K, Ota T, Manabe Y, Okamoto K, Koizumi A, Abe K (2012) Clinical features of SCA36: a novel spinocerebellar ataxia with motor neuron involvement (Asidan). Neurology 79(4):333–341. doi:10.1212/WNL.0b013e318260436f
Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM, Weber C, Mandel JL, Cancel G, Abbas N, Durr A, Didierjean O, Stevanin G, Agid Y, Brice A (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 14(3):285–291. doi:10.1038/ng1196-285
Infante J, Berciano J, Volpini V, Corral J, Polo JM, Pascual J, Combarros O (2004) Spinocerebellar ataxia type 2 with levodopa-responsive Parkinsonism culminating in motor neuron disease. Mov Disord 19(7):848–852. doi:10.1002/mds.20090
Kim JM, Hong S, Kim GP, Choi YJ, Kim YK, Park SS, Kim SE, Jeon BS (2007) Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. Arch Neurol 64(10):1510–1518. doi:10.1001/archneur.64.10.1510
Koyano S, Uchihara T, Fujigasaki H, Nakamura A, Yagishita S, Iwabuchi K (1999) Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study. Neurosci Lett 273(2):117
Laffita-Mesa JM, Bauer PO, Kouri V, Pena Serrano L, Roskams J, Almaguer Gotay D, Montes Brown JC, Martinez Rodriguez PA, Gonzalez-Zaldivar Y, Almaguer Mederos L, Cuello-Almarales D, Aguiar Santiago J (2012) Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications. Hum Genet 131(4):625. doi:10.1007/s00439-011-1101-y
Le Pira F, Zappala G, Saponara R, Domina E, Restivo D, Reggio E, Nicoletti A, Giuffrida S (2002) Cognitive findings in spinocerebellar ataxia type 2: relationship to genetic and clinical variables. J Neurol Sci 201(1–2):53–57
Lee T, Li YR, Ingre C, Weber M, Grehl T, Gredal O, de Carvalho M, Meyer T, Tysnes OB, Auburger G, Gispert S, Bonini NM, Andersen PM, Gitler AD (2011) Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum Mol Genet 20(9):1697–1700. doi:10.1093/hmg/ddr045
Liu X, Lu M, Tang L, Zhang N, Chui D, Fan D (2013) ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging 34(9):2236 e2235–2236 e2238. doi:10.1016/j.neurobiolaging.2013.04.009
Lu CS, Wu Chou YH, Kuo PC, Chang HC, Weng YH (2004) The Parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol 61(1):35–38. doi:10.1001/archneur.61.1.35
Lu CS, Wu Chou YH, Yen TC, Tsai CH, Chen RS, Chang HC (2002) Dopa-responsive Parkinsonism phenotype of spinocerebellar ataxia type 2. Mov Disord 17(5):1046–1051. doi:10.1002/mds.10243
Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122(1):111–113. doi:10.1007/s00401-011-0845-8
Nanetti L, Fancellu R, Tomasello C, Gellera C, Pareyson D, Mariotti C (2009) Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature. J Neurol 256(11):1926–1928. doi:10.1007/s00415-009-5237-9
Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130–133
Nihei Y, Ito D, Suzuki N (2012) Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and fused in sarcoma (FUS). J Biol Chem 287(49):41310. doi:10.1074/jbc.M112.398099
Orsi L, D’Agata F, Caroppo P, Franco A, Caglio MM, Avidano F, Manzone C, Mortara P (2011) Neuropsychological picture of 33 spinocerebellar ataxia cases. J Clin Exp Neuropsychol 33(3):315–325. doi:10.1080/13803395.2010.518139
Pang JT, Giunti P, Chamberlain S, An SF, Vitaliani R, Scaravilli T, Martinian L, Wood NW, Scaravilli F, Ansorge O (2002) Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases. Brain 125(Pt 3):656–663
Proukakis C, Houlden H, Schapira AH (2013) Somatic alpha-synuclein mutations in Parkinson’s disease: hypothesis and preliminary data. Mov Disord 28(6):705–712. doi:10.1002/mds.25502
Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg JR, Figueroa C, Sahba S (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14(3):269–276. doi:10.1038/ng1196-269
Pulst SM, Santos N, Wang D, Yang H, Huynh D, Velazquez L, Figueroa KP (2005) Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain 128(Pt 10):2297–2303. doi:10.1093/brain/awh586
Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M, Consortium I, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257–268. doi:10.1016/j.neuron.2011.09.010
Reynaldo-Arminan RD, Reynaldo-Hernandez R, Paneque-Herrera M, Prieto-Avila L, Perez-Ruiz E (2002) Mental disorders in patients with spinocerebellar ataxia type 2 in Cuba. Rev Neurol 35(9):818–821
Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, Adamson J, Li M, Volkening K, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Woodruff BK, Knopman DS, White CL 3rd, Van Gerpen JA, Meschia JF, Mackenzie IR, Boylan K, Boeve BF, Miller BL, Strong MJ, Uitti RJ, Younkin SG, Graff-Radford NR, Petersen RC, Wszolek ZK, Dickson DW, Rademakers R (2011) Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet 20(16):3207. doi:10.1093/hmg/ddr227
Rub U, Seidel K, Ozerden I, Gierga K, Brunt ER, Schols L, de Vos RA, den Dunnen W, Schultz C, Auburger G, Deller T (2007) Consistent affection of the central somatosensory system in spinocerebellar ataxia type 2 and type 3 and its significance for clinical symptoms and rehabilitative therapy. Brain Res Rev 53(2):235–249. doi:10.1016/j.brainresrev.2006.08.003
Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, Koide R, Saito M, Sato A, Tanaka T, Hanyu S, Takiyama Y, Nishizawa M, Shimizu N, Nomura Y, Segawa M, Iwabuchi K, Eguchi I, Tanaka H, Takahashi H, Tsuji S (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 14(3):277–284. doi:10.1038/ng1196-277
Shan DE, Soong BW, Sun CM, Lee SJ, Liao KK, Liu RS (2001) Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive Parkinsonism. Ann Neurol 50(6):812–815
Sobczak K, Krzyzosiak WJ (2005) CAG repeats containing CAA interruptions form branched hairpin structures in spinocerebellar ataxia type 2 transcripts. J Biol Chem 280(5):3898–3910. doi:10.1074/jbc.M409984200
Storey E, Forrest SM, Shaw JH, Mitchell P, Gardner RJ (1999) Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol 56(1):43–50
Takao M, Aoyama M, Ishikawa K, Sakiyama Y, Yomono H, Saito Y, Kurisaki H, Mihara B, Murayama S (2011) Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology. BMJ Case Rep. doi:10.1136/bcr.01.2011.3685
Tazen S, Figueroa K, Kwan JY, Goldman J, Hunt A, Sampson J, Gutmann L, Pulst SM, Mitsumoto H, Kuo SH (2013) Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2. JAMA Neurol. doi:10.1001/jamaneurol.2013.443
Toyoshima Y, Tanaka H, Shimohata M, Kimura K, Morita T, Kakita A, Takahashi H (2011) Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. Acta Neuropathol 122(3):375–378. doi:10.1007/s00401-011-0862-7
Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V, Dubois B, Matthijs G, van den Berg LH, Robberecht W (2011) Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 76(24):2066–2072. doi:10.1212/WNL.0b013e31821f445b
Van Langenhove T, van der Zee J, Engelborghs S, Vandenberghe R, Santens P, Van den Broeck M, Mattheijssens M, Peeters K, Nuytten D, Cras P, De Deyn PP, De Jonghe P, Cruts M, Van Broeckhoven C (2012) Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts. Neurobiol Aging 33(5):1004 e1017–1004 e1020. doi:10.1016/j.neurobiolaging.2011.09.025
Wojciechowska M, Krzyzosiak WJ (2011) CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders. RNA Biol 8(4):565–571. doi:10.4161/rna.8.4.15397
Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, Margolis J, Peterson M, Markowski TW, Ingram MA, Nan Z, Forster C, Low WC, Schoser B, Somia NV, Clark HB, Schmechel S, Bitterman PB, Gourdon G, Swanson MS, Moseley M, Ranum LP (2011) Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci USA 108(1):260–265. doi:10.1073/pnas.1013343108
Acknowledgments
We are indebted to the family of the index case for supporting this research and their provision of DNA samples. In addition, we are grateful to the department of Clinical Genetics, Churchill Hospital, Oxford, for technical support. We acknowledge the Oxford Brain Bank, supported by the Medical Research Council (MRC), Brains for Dementia Research (BDR) and the NIHR Oxford Biomedical Research Centre. DB is funded by an Oxfordshire Health Services Research Committee (OHSRC)/Nuffield Oxford Hospitals Fund (NOHF)/BRC Fellowship. The Oxford Brain Bank is supported by the Medical Research Council (OA) and Brains for Dementia Research (OA). SE and OA are supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bäumer, D., East, S.Z., Tseu, B. et al. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion. Acta Neuropathol 128, 597–604 (2014). https://doi.org/10.1007/s00401-014-1277-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-014-1277-z